Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gadolinium Nanotubes Enable MRI Tracking of Transplanted Stem Cells

By LabMedica International staff writers
Posted on 24 Nov 2010
The use of high contrast nanotubes are expected to increase the sensitivity of magnetic resonance imaging (MRI) to the point that this technique will be able to follow the movement of transplanted stem cells within the body of a patient.

The highly toxic rare earth element gadolinium is used in a chelated form as a contrast reagent for MRI. More...
A recent study has carried this use a step farther by sequestering the gadolinium inside carbon nanotubes. The resulting microscopic tubes are called "gadonanotubes,” and investigators at Rice University (Houston, TX, USA) have used them to label pig bone marrow-derived mesenchymal stem cells (MSCs).

They reported in the October 20, 2010, online edition of the journal Biomaterials that images produced using gadonanotubes were approximately 40 times brighter and clearer than traditional MRI images. In particular, the nanotubes readily entered and became concentrated in abnormal tissue such as tumors or damaged heart muscle. This level of sensitivity is such that it will allow tracking of labeled cells, such as stem cells, inside the body of a patient. The magnetic properties of gadolinium will allow the clinician to guide the nanoparticle-labeled cells to precise locations where they can be deposited and allowed to grow and differentiate.

"MRI images are 40 times clearer, brighter, and easier to read than before,” said senior author Dr. Lon Wilson, professor of chemistry at Rice University. "Until now, there has not been an effective way to track the cells within the body after they are delivered to the heart, and to test their effectiveness while they are in the heart.”

Related Links:
Rice University




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.